Computational strategies for PROTAC drug discovery
Proteolysis-targeting chimeras (PROTACs), a novel targeted protein degradation technology for potential clinical drug discovery, is composed of a protein-targeting ligand covalently linked to an E3 ligase ligand. Through recruiting E3 ligase to target proteins, PROTACs elicit ubiquitination and subs...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2023-02-01
|
Series: | Acta Materia Medica |
Subjects: | |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2022-0041 |